Shopping Cart
- Remove All
- Your shopping cart is currently empty
RLX is a PI3K/Akt/FoxO3a signaling inhibitor in experimental colon cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 1.444 € | 6-8 weeks | |
50 mg | 1.881 € | 6-8 weeks | |
100 mg | 2.375 € | 6-8 weeks |
Description | RLX is a PI3K/Akt/FoxO3a signaling inhibitor in experimental colon cancer. |
Alias | THA-Q, THA Q, PD-139530, PD139530, PD 139530 |
Molecular Weight | 214.26 |
Formula | C13H14N2O |
Cas No. | 4425-23-4 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.